Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mogamulizumab in Relapsed/Refractory PTCL
NCT01611142Phase 2Completed
- Sponsor
- Kyowa Kirin
- Start
- Apr 2012
- Primary completion
- May 2015
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 6
01
Overview
Phase 2, open-label, single-arm trial of mogamulizumab in peripheral T-cell lymphoma (PTCL), sponsored by Kyowa Kirin. Primary endpoint: Overall Response Rate. Started Apr 2012; status: completed.
02
Drugs
mogamulizumab
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT01611142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01611142.